Sphera-Funds-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
114
Total Value
419305182
Accession Number
0001496201-25-000007
Form Type
13F-HR
Manager Name
Sphera-Funds-Management
Data Enrichment
92% identified
105 identified9 unidentified

Holdings

114 positions
Manager:
Search and click to pin securities to the top
Page 2 of 6
NOVARTIS AG
Shares:50.0K
Value:$5.6M
Merck & Co., Inc.
Shares:59.6K
Value:$5.3M
686688AC6
Shares:5.0M
Value:$5.2M
NICE Ltd.
Shares:33.3K
Value:$5.1M
GSK plc
Shares:130.0K
Value:$5.0M
SOLAREDGE TECHNOLOGIES, INC.
Shares:309.2K
Value:$5.0M
89bio, Inc.
Shares:618.3K
Value:$4.5M
Merus N.V.
Shares:106.5K
Value:$4.5M
Immatics N.V.
Shares:921.1K
Value:$4.2M
Apellis Pharmaceuticals, Inc.
Shares:181.3K
Value:$4.0M
578784100
Shares:355.6K
Value:$3.9M
Praxis Precision Medicines, Inc.
Shares:100.0K
Value:$3.8M
Travere Therapeutics, Inc.
Shares:200.0K
Value:$3.6M
Savara Inc
Shares:1.3M
Value:$3.6M
ARROWHEAD PHARMACEUTICALS, INC.
Shares:277.6K
Value:$3.5M
Dyne Therapeutics, Inc.
Shares:329.3K
Value:$3.4M
Annexon, Inc.
Shares:1.8M
Value:$3.4M
Janux Therapeutics, Inc.
Shares:125.8K
Value:$3.4M
CYBIN INC.
Shares:527.2K
Value:$3.3M
Immunovant, Inc.
Shares:194.6K
Value:$3.3M